METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Clinical trials for METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE trials appear
Sign up with your email to follow new studies for METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a probiotic supplement help reverse fatty liver?
Disease control CompletedThis study tests whether a daily capsule containing fragments of a probiotic bacterium (L. rhamnosus) can reduce liver fat and improve blood markers in adults with metabolic dysfunction-associated steatotic liver disease (MASLD). Participants take either the supplement or a place…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Bogomolets National Medical University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug shows promise in shrinking fatty liver
Disease control CompletedThis study tested a new medication called efinopegdutide in 124 adults with fatty liver disease (also called MASLD). The goal was to see if taking the drug every two weeks or every week could safely reduce liver fat. After 28 weeks, the drug helped lower liver fat, and researcher…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Which ketogenic diet works best? new study compares meal replacements vs. natural foods
Disease control CompletedThis study looked at how well adults with obesity or complicated overweight could stick to different very low-calorie ketogenic diets (VLCKD) in a real-world clinic. Participants chose one of four diet plans, ranging from all-natural foods to all meal replacements, and followed a…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: University of Bologna • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Rice bran shows promise for fatty liver in small study
Disease control CompletedThis study looked at whether adding rice bran to nutrition education helps people with fatty liver disease. 58 overweight or obese adults with moderate fatty liver were split into two groups: one got nutrition education alone, the other got nutrition education plus rice bran. Res…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Shih Chien University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
AI-Powered liver test could spot hidden risks in fatty liver patients
Diagnosis CompletedThis study looked at over 1,200 adults with metabolic fatty liver disease (MASLD) to see if a new digital test, called FibroNest Ph-FCS, can predict who will develop serious liver complications. The test uses computer analysis of standard liver biopsy images to measure scarring. …
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: PharmaNest, Inc • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
Could adding a second diabetes drug early save lives?
Knowledge-focused CompletedThis study analyzed health records of over 118,000 adults with obesity, type 2 diabetes, and related heart, kidney, and liver conditions. Researchers compared people who added a second type of diabetes drug (GLP-1 or SGLT2) early to those who did not. The goal was to see if early…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Chung Shan Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
10,000 seniors studied to predict fatty liver dangers
Knowledge-focused CompletedThis study looked at 10,000 older adults (age 60+) with fatty liver disease to find out what increases their risk for serious liver problems like scarring, cirrhosis, or liver cancer. Researchers used medical records and yearly check-ups to build a computer model that predicts th…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Digital biopsy score may predict liver failure risk in fatty liver patients
Knowledge-focused CompletedThis study looked at whether a computer analysis of liver biopsy images (called FibroNest Ph-FCS) can predict future liver complications in people with a type of fatty liver disease called MASLD. Researchers reviewed medical records from 1,578 patients to see if the digital score…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: PharmaNest, Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
MASH awareness survey completed: no treatment, just insights
Knowledge-focused CompletedThis study used online questionnaires to understand how well healthcare providers and people with or at risk for MASH (a liver disease) understand the links between MASH and heart, kidney, and metabolic conditions. About 1,330 participants completed the 25-minute survey. The goal…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC